Gene mutation increases thromboembolism risk in women taking tamoxifen16 June 2010
Women taking tamoxifen for early-stage breast cancer who developed blood clots were more likely to carry a gene mutation for clotting than women taking tamoxifen who did not develop a clot, according to an online study published on 16 June in the Journal of the National Cancer Institute.Read the free editorial online here.
Published in the Journal of the National Cancer Institute, Advance Access, 16 June 2010.
Read the full press release here.
For more information and the article: JNCI press room